Bei Wang currently holds the position of Director at Regeneron, having progressed through various roles, including Associate Director, Senior Staff Scientist, Staff Scientist, and Scientist since January 2013. Prior experience includes serving as a Visiting Scientist and Research Associate at The Rockefeller University from July 2007 to December 2017, where Bei Wang focused on a monoclonal antibody adjuvant for pancreatic cancer vaccines and managed a team in cancer vaccine development. Prior to this, Bei Wang completed a postdoctoral fellowship at the Ralph Steinman Laboratory, exploring dendritic cell functions in tumor immunotherapy, and conducted graduate studies at the University of Florida, culminating in a Ph.D. in Immunology. Medical training began with an internship at Zhongshan Hospital after obtaining an MD from Fudan University.
This person is not in any teams
This person is not in any offices